Paras Healthcare Limited, operating under the Paras Health brand, is advancing its public offering plans, drawing attention from market participants tracking the healthcare and hospital sector. Based in Gurugram, Haryana, the clinical specialty-led hospital platform delivers tertiary and quaternary healthcare services across multiple regions. The upcoming public issue establishes a price band of ₹660 to ₹693 per equity share, providing investors with structured entry terms into a specialized regional hospital network.
Company Overview and Hospital Infrastructure
The company maintains a growing footprint consisting of eight hospitals with an aggregate capacity of 2,211 beds as of March 31, 2026. Its operational reach spans across five states and one union territory, covering locations such as Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand, and Srinagar in Jammu and Kashmir. The flagship Gurugram facility has maintained operations for 20 years, while the Patna unit has operated for 12 years. Newer additions include the Srinagar and Kanpur facilities, which have run for three years and two years respectively.
Infrastructure deployment emphasizes critical care capabilities. The hospital network featured 559 ICU beds as of March 31, 2026, marking an expansion from 425 ICU beds in FY2024. Across these facilities, the platform employed 1,011 doctors and 1,665 nurses at the close of FY2026. Structurally, four units operate as super-specialty tertiary care hospitals, while the remaining four function as multi-specialty tertiary care hospitals. Real estate arrangements rely heavily on leased premises, with six of the eight units operating on lease agreements—five utilizing revenue-share arrangements alongside long-term leases, and one functioning under a public-private partnership.
Clinical Specializations and Revenue Mix
The business reports through a single healthcare services segment. Operational focus centers heavily on CONGOR specialties, encompassing cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. These six core domains generated 74.70% of the total revenue from operations in FY2026. Individual specialty contributions are led by oncology at 21.63%, neuro sciences at 13.03%, and cardiac sciences at 12.78%.
Geographical revenue distribution highlights a strong presence in tier 2 cities. Hospitals situated outside Gurugram accounted for 68.18% of FY2026 revenue from operations, compared to 62.35% in FY2024. Payment streams are diversified across three primary categories. Government schemes and public sector undertakings contributed 41.28% of FY2026 revenue, self-pay patients accounted for 33.88%, and insurance third-party administrators represented 24.84%. By comparison, these respective shares stood at 29.76%, 40.63%, and 29.61% in FY2024.
Operational Metrics and Promoter Profile
Operating efficiency indicators demonstrated positive progression through FY2026. Operational beds increased to 1,502 from 1,465, while the bed occupancy rate improved to 61.75% from 50.78%. Total occupied bed days reached 3,38,321, up from 2,68,927. In-patient volumes climbed to 1,15,496 and out-patient volumes reached 7,78,707 in FY2026, alongside 39,687 surgical procedures performed across the network.
Financial productivity per bed is measured through average revenue per occupied bed, which stood at ₹47,397.82 per day in FY2026. Significant variance exists across locations, with the Gurugram facility recording ₹70,925.76 per day and the Darbhanga unit registering ₹19,980.75 per day. The average length of stay across the network was recorded at 2.93 days.
The company is guided by Dr. Dharminder Kumar Nagar, who serves as the Managing Director and promoter. Associated with the enterprise since 2003, he brings over 22 years of experience in the healthcare industry. His academic background includes an MBBS degree from the University of Mysore and a Master of Philosophy in hospital and health systems management from BITS Pilani.
Market and Business Analysis
Market Impact and Tier 2 Strategy
The positioning of Paras Healthcare in tier 2 urban centers creates a distinct operational advantage. By securing 68.18% of its operational revenue outside Tier 1 hubs like Gurugram, the platform capitalizes on underserved healthcare markets where specialized tertiary care remains scarce. This geographical deployment insulates the business from intense metropolitan competition while capturing rising healthcare expenditure in emerging urban clusters. The deliberate tilt toward government schemes and public sector undertakings, which expanded to 41.28% of revenue, ensures steady patient volumes despite lower realization rates compared to self-pay or insured segments.
Operational Scalability and Efficiency
An analysis of operational metrics reflects improved asset utilization. The jump in bed occupancy to 61.75% alongside an expansion in operational beds to 1,502 demonstrates that network additions are effectively absorbing patient demand. Critical care scaling—evidenced by the growth in ICU beds to 559—supports high-margin tertiary procedures within the CONGOR specialties. However, the wide gap in average revenue per occupied bed between the Gurugram unit (₹70,925.76) and regional units like Darbhanga (₹19,980.75) highlights varying regional pricing power and local purchasing parity.
| Operational Parameter | FY2024 | FY2026 | Change / Trend | Analysis |
|---|---|---|---|---|
| Operational Beds | 1,465 | 1,502 | +37 beds | Moderate capacity expansion across network units. |
| Bed Occupancy Rate | 50.78% | 61.75% | +10.97% | Significant improvement in asset utilization and patient inflow. |
| Occupied Bed Days | 2,68,927 | 3,38,321 | +69,394 days | Stronger in-patient engagement and extended ward utility. |
| ICU Beds | 425 | 559 | +134 beds | Enhanced critical care capacity supporting complex procedures. |
| In-Patient Volumes | 81,047 | 1,15,496 | +34,449 patients | Broadened clinical adoption and network reach. |
Valuation and Issue Context
With the price band fixed at ₹660 to 693, the public offering values the hospital platform in line with broader sector multiples for regional healthcare providers. The reliance on leased real estate—with six of eight hospitals operating on lease structures—keeps capital expenditure oriented toward medical equipment and clinical talent rather than land acquisition, preserving asset-light growth dynamics where feasible. The concentration of revenue in specialized tertiary verticals ensures that high-value treatments continue to anchor top-line stability.
Key Takeaways
- Paras Healthcare operates a network of eight hospitals with an aggregate capacity of 2,211 beds across five states and one union territory.
- The IPO price band is established at ₹660 to ₹693 per equity share.
- CONGOR specialties (cardiac, oncology, neuro, gastro, orthopedics, renal) drive 74.70% of FY2026 operating revenue.
- Tier 2 facilities outside Gurugram generate 68.18% of total revenue, highlighting regional market penetration.
- Bed occupancy improved to 61.75% in FY2026, supported by 559 ICU beds and an in-patient volume of 1,15,496.
- Government schemes and PSUs account for 41.28% of revenue streams, followed by self-pay patients at 33.88% and insurance at 24.84%.
Frequently Asked Questions
The price band for the public issue is set at ₹660 to ₹693 per equity share.
As of March 31, 2026, the company operates a network of eight hospitals with an aggregate capacity of 2,211 beds.
The core specialties, termed CONGOR, include cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences, which together contributed 74.70% of FY2026 revenue.
Dr. Dharminder Kumar Nagar serves as the Managing Director and promoter, bringing over 22 years of experience in the healthcare sector.
Hospitals located outside Gurugram contributed 68.18% of the total revenue from operations in FY2026.
Six of the eight hospitals operate on leased premises, with five utilizing revenue share arrangements and long-term leases, and one functioning under a public-private partnership.
The bed occupancy rate rose to 61.75% in FY2026, compared to 50.78% in FY2024.
In FY2026, government schemes and public sector undertakings accounted for 41.28% of revenue, self-pay patients contributed 33.88%, and insurance third-party administrators represented 24.84%.
